Exelixis
EXEL
#1807
Rank
$11.77 B
Marketcap
$43.92
Share price
2.86%
Change (1 day)
27.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company